Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials and Announces Expected 2023 Milestones, Including Initial Data Read-Outs from Both Programs
Stock Information for Q32 Bio Inc Com
Loading
Please wait while we load your information from QuoteMedia.